Express-TekSM Production enables customers to have their products enter production in days instead of weeks, significantly shortening turnaround time New...
GARDEN CITY, NY, Aug. 13, 2024 (GLOBE NEWSWIRE) -- ProPhase Labs, Inc. (NASDAQ: PRPH), a next-generation biotech, genomics, and diagnostics...
DUBLIN--(BUSINESS WIRE)--The "Orphan Drugs and Rare Diseases Conference" has been added to ResearchAndMarkets.com's offering. The 2 day Orphan Drugs and...
ASHEVILLE, N.C., Aug. 9, 2024 /PRNewswire/ -- Genova Diagnostics, a global leader in clinical laboratory services, proudly announces the launch of...
- Conference Call/Webcast Scheduled for Today at 4:30 PM ET - STONY BROOK, NY / ACCESSWIRE / August 8, 2024...
CHICAGO, Aug. 8, 2024 /PRNewswire/ -- The global Label-Free Detection Market is expected to grow from USD 515 million in 2024...
Clinical research study at leading U.S. hospital will further validate the efficacy of advanced, AI-powered magnetocardiography for transformative cardiac diagnostics...
SphingoTec GmbH has successfully secured funding to drive its global expansion, including the US market, through strategic collaborations.The investment round...
NEW YORK, Aug. 7, 2024 /PRNewswire/ -- The global healthcare revenue cycle management (RCM) software market size is estimated to grow...
DALLAS and NEWPORT BEACH, Calif., Aug. 7, 2024 /PRNewswire/ -- Epilog Partners, a private equity platform built by investors, operators...
2024 shaping up to be a strong year for biopharma SAN FRANCISCO, Aug. 7, 2024 /PRNewswire/ -- In the first half...
Unique partnership with Medtronic will enable continuous glucose monitoring (CGM) sensors based on Abbott's FreeStyle Libre sensing technology to integrate with...
Putnam County Government teams up with PeopleOne Health and RosenCare to deliver barrier-free employee healthcare; opens doors to Palatka health...
GARDEN CITY, NY, Aug. 07, 2024 (GLOBE NEWSWIRE) -- ProPhase Labs Inc. (NASDAQ: PRPH), announced today that they will be...
-- Reported positive topline data from pivotal Phase 3 BROOKLYN trial evaluating obicetrapib in patients with HeFH; achieved primary endpoint...
STONY BROOK, NY / ACCESSWIRE / August 7, 2024 / Applied DNA Sciences, Inc. (NASDAQ:APDN) ("Applied DNA" or the "Company"),...
Rachael Buck Ph. D, Velocity UK Country Head Rachael Buck Ph. D, Velocity UK Country Head DURHAM, N.C., Aug. 07,...
August 7, 2024News Release BioPorto A/S to Host Second Quarter 2024 Earnings Webcast & Investor Meeting COPENHAGEN, DENMARK and BOSTON, MA,...
Company to host conference call and webcast on Wednesday, August 28th at 8:30am EDT LYON, France, August 7, 2024 --...
Results Release and Webinar Discussion on Morning of August 14, 2024MISSISSAUGA, Ontario, Aug. 07, 2024 (GLOBE NEWSWIRE) -- Microbix Biosystems...